LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 63.26 | 27.76 | 5838 | 6465 | 0.9029 | 0.9742 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 63.26 | 27.76 | 2542 | 6465 | 0.3932 | 0.7761 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 63.26 | 27.76 | 4987 | 6465 | 0.7713 | 0.9350 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 64.97 | 27.76 | 3514 | 6656 | 0.5279 | 0.8447 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 64.97 | 27.76 | 6012 | 6656 | 0.9031 | 0.9744 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 64.97 | 27.76 | 2419 | 6656 | 0.3634 | 0.7596 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 64.97 | 27.76 | 5148 | 6656 | 0.7734 | 0.9360 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 66.67 | 27.76 | 3383 | 6695 | 0.5053 | 0.8347 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 66.67 | 27.76 | 6303 | 6695 | 0.9414 | 0.9848 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 66.67 | 27.76 | 2330 | 6695 | 0.3480 | 0.7503 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 66.67 | 27.76 | 5316 | 6695 | 0.7939 | 0.9425 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 68.37 | 27.76 | 3840 | 6879 | 0.5582 | 0.8586 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 68.37 | 27.76 | 6479 | 6879 | 0.9418 | 0.9850 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 68.37 | 27.76 | 2582 | 6879 | 0.3753 | 0.7682 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 68.37 | 27.76 | 5464 | 6879 | 0.7943 | 0.9429 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 70.08 | 27.76 | 3898 | 6849 | 0.5691 | 0.8630 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 70.08 | 27.76 | 6643 | 6849 | 0.9698 | 0.9923 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 70.08 | 27.76 | 2603 | 6849 | 0.3800 | 0.7707 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 70.08 | 27.76 | 5619 | 6849 | 0.8203 | 0.9508 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 71.78 | 27.76 | 3898 | 6893 | 0.5655 | 0.8617 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 71.78 | 27.76 | 6845 | 6893 | 0.9930 | 0.9982 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 71.78 | 27.76 | 2440 | 6893 | 0.3540 | 0.7553 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 71.78 | 27.76 | 5775 | 6893 | 0.8378 | 0.9560 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 73.48 | 27.76 | 4522 | 6957 | 0.6499 | 0.8947 | MN20160318_Q01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 73.48 | 27.76 | 7010 | 6957 | 1.0075 | 1.0019 | MN20160318_Q01 | C19 |